Multiple myeloma, version 1.2013.

Journal Article

These NCCN Guidelines Insights highlight the important updates/changes specific to the management of relapsed or progressive disease in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include the addition of new regimens as options for salvage therapy and strategies to mitigate the adverse effects and risks associated with newer regimens for the treatment of multiple myeloma.

Full Text

Duke Authors

Cited Authors

  • Anderson, KC; Alsina, M; Bensinger, W; Biermann, JS; Cohen, AD; Devine, S; Djulbegovic, B; Faber, EA; Gasparetto, C; Hernandez-Illizaliturri, F; Huff, CA; Kassim, A; Krishnan, AY; Liedtke, M; Meredith, R; Raje, N; Schriber, J; Singhal, S; Somlo, G; Stockerl-Goldstein, K; Treon, SP; Weber, D; Yahalom, J; Yunus, F; Shead, DA; Kumar, R

Published Date

  • January 1, 2013

Published In

Volume / Issue

  • 11 / 1

Start / End Page

  • 11 - 17

PubMed ID

  • 23307977

Pubmed Central ID

  • 23307977

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0004

Language

  • eng

Conference Location

  • United States